The SPEAK UP FOR COPD campaign is intended to raise awareness and understanding of COPD amongst policymakers and healthcare decision makers by amplifying the voices of patients, the COPD community and the public. We have one critical goal...
Read more
The Observational & Pragmatic Research Institute (OPRI) is proud to announce a new publication, ”What have we learnt from real-life research in asthma and COPD? Standards and novel designs for the future”. “It is common for...
Read more
Established by a partnership between Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), Changi General Hospital (CGH), Singapore General Hospital (SGH), and Tan Tock Seng Hospital...
Read more
You wouldn’t think twice about asking your asthma patients to quit smoking, but have you ever asked them whether they have allergic rhinitis? Not such a strange question if you consider that 80% of patients with #asthma have #allergicrhinitis and...
Read more
OPRI is excited to share a milestone in asthma phenotype recognition! The ISAR #publication titled, ”Eosinophilic and Non eosinophilic Asthma, An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma...
Read more
Are severe asthma patients getting the right treatment? Research has shown that you can’t take a one-size-fits-all approach to severe asthma management due to differences in phenotypes. So, we developed the International Severe Asthma Registry...
Read more
In this video, DDL Invites Professor David Price to speak in the DDL 2021 Virtual Video Conference, Professor Price explains the changes in GINA asthma management and what does this mean for treating patients with asthma. Check the full...
Read more
We chat about the experiences of Gabby Perry, a student with severe #asthma, and the dual-edged swords that are steroids. Along with Gabby, Syed Ali, medical affairs manager at AstraZeneca, and OPRI’s own Professor David Price take us through the...
Read moreThe CONQUEST Quality Standards (QS) aim to enhance care for COPD patients at a higher, yet modifiable, risk of COPD exacerbations, increased morbidity and mortality. Learn more about the QS underpinning the CONQUEST program by viewing this slide...
Read more
The Observational and Pragmatic Research Institute is proud to announce the launch of the Pragmatic Evaluation of an Improvement Program for People Living with Modifiable High-risk COPD (PREVAIL) study, in collaboration with AstraZeneca and...
Read more
New COVID-19 quality improvement programme available to GP practices across the United Kingdom First-of-its-kind quality improvement programme to exclusively focus on Covid-19 and the management of chronic conditions in the context of a pandemic...
Read more
Bleecker ER, Menzies-Gow A, Price D, Bourdin A, Sweet S, Martin A, Alacqua M, Tran TN. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. Am J Respir Crit Care Med. 2020;201:276–93. Steroids, either in the form of...
Read more